WEST PHARMACEUTICAL SVSC INC's ticker is WST and the CUSIP is 955306105. A total of 288 filers reported holding WEST PHARMACEUTICAL SVSC INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
About WEST PHARMACEUTICAL SVSC INC
West Pharmaceutical Services, Inc. is a global leader in innovative solutions for injectable drug administration. The company has been in business for over 100 years and has a strong reputation for quality and reliability. West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania, and has operations in North and South America, Europe, Asia, and Australia.
West Pharmaceutical Services, Inc. has a diverse portfolio of products and services that cater to the needs of the pharmaceutical and biotech industries. The company's products include stoppers and seals for vials, syringe and cartridge components, and drug delivery systems. West Pharmaceutical Services, Inc. also offers analytical and testing services, as well as contract manufacturing services.
The company's success can be attributed to its commitment to innovation and customer satisfaction. West Pharmaceutical Services, Inc. invests heavily in research and development to create new products and improve existing ones. The company also works closely with its customers to understand their needs and provide customized solutions.
West Pharmaceutical Services, Inc. has a strong financial position, with a market capitalization of over $20 billion. The company's revenue has been steadily increasing over the past few years, and it has a solid balance sheet with low debt levels.
In conclusion, West Pharmaceutical Services, Inc. is a well-established and reputable company that provides innovative solutions for injectable drug administration. The company's commitment to innovation and customer satisfaction has helped it maintain its position as a global leader in the industry. With a strong financial position and a diverse portfolio of products and services, West Pharmaceutical Services, Inc. is well-positioned for continued success in the future.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $205,000 | -19.9% | 1,364 | -47.8% | 0.00% | -33.3% |
| Q4 2018 | $256,000 | -20.7% | 2,612 | -0.2% | 0.01% | 0.0% |
| Q3 2018 | $323,000 | -4.7% | 2,617 | -23.3% | 0.01% | -14.3% |
| Q2 2018 | $339,000 | -38.9% | 3,412 | -45.7% | 0.01% | -41.7% |
| Q1 2018 | $555,000 | -10.8% | 6,283 | -0.4% | 0.01% | 0.0% |
| Q4 2017 | $622,000 | -21.3% | 6,308 | -23.1% | 0.01% | -29.4% |
| Q3 2017 | $790,000 | +8.7% | 8,208 | +6.7% | 0.02% | 0.0% |
| Q2 2017 | $727,000 | +23.0% | 7,692 | +6.2% | 0.02% | +21.4% |
| Q1 2017 | $591,000 | -8.5% | 7,240 | -5.0% | 0.01% | -12.5% |
| Q4 2016 | $646,000 | +36.0% | 7,621 | +19.6% | 0.02% | +33.3% |
| Q3 2016 | $475,000 | +40.5% | 6,373 | +43.1% | 0.01% | +33.3% |
| Q2 2016 | $338,000 | +15.0% | 4,455 | +4.9% | 0.01% | +12.5% |
| Q1 2016 | $294,000 | – | 4,246 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| McCollum Christoferson Group LLC | 66,099 | $10,064,000 | 4.02% |
| Hoover Financial Advisors, Inc. | 43,272 | $6,588,000 | 3.64% |
| Durable Capital Partners LP | 942,821 | $143,544,000 | 2.92% |
| Kistler-Tiffany Companies, LLC | 49,418 | $7,429,000 | 2.63% |
| GRACE & WHITE INC /NY | 43,590 | $6,637,000 | 2.33% |
| SECURITY ASSET MANAGEMENT | 21,279 | $3,240,000 | 2.30% |
| Intermede Investment Partners Ltd | 248,461 | $37,828,000 | 2.23% |
| AMI ASSET MANAGEMENT CORP | 219,667 | $33,444,000 | 2.11% |
| TAP Consulting, LLC | 20,557 | $3,130,000 | 2.11% |
| RIVERBRIDGE PARTNERS LLC | 584,002 | $88,914,000 | 1.86% |